Cargando…
Elucidating the Innate Immunological Effects of Mild Magnetic Hyperthermia on U87 Human Glioblastoma Cells: An In Vitro Study
Cancer immunotherapies have been approved as standard second-line or in some cases even as first-line treatment for a wide range of cancers. However, immunotherapy has not shown clinically relevant success in glioblastoma (GBM). This is principally due to the brain’s “immune-privileged” status and t...
Autores principales: | Persano, Stefano, Vicini, Francesco, Poggi, Alessandro, Fernandez, Jordi Leonardo Castrillo, Rizzo, Giusy Maria Rita, Gavilán, Helena, Silvestri, Niccolo, Pellegrino, Teresa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537446/ https://www.ncbi.nlm.nih.gov/pubmed/34683961 http://dx.doi.org/10.3390/pharmaceutics13101668 |
Ejemplares similares
-
Exosome Proteome of U-87MG Glioblastoma Cells
por: Chun, Sohyun, et al.
Publicado: (2016) -
Investigation of platinum nanoparticle properties against U87 glioblastoma multiforme
por: Kutwin, Marta, et al.
Publicado: (2016) -
Role for Metallothionein-3 in the Resistance
of Human U87 Glioblastoma Cells to Temozolomide
por: Santangelo, Rosa, et al.
Publicado: (2020) -
Aptamer-Driven Toxin Gene Delivery in U87 Model Glioblastoma Cells
por: di Leandro, Luana, et al.
Publicado: (2021) -
Chemosensitization of U-87 MG Glioblastoma Cells by Neobavaisoflavone towards Doxorubicin and Etoposide
por: Maszczyk, Mateusz, et al.
Publicado: (2022)